Seizure Disorder, Partial
5
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
100%
5 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures
Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures
To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.